Scilex Holding Co (SCLXW) stock

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Scilex EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Scilex's EPS for the twelve months ending Sep 30, 2024 was -$24.29. For fiscal 2025 it was -$36.48. The highest annual figure on record is -$5.95 in fiscal 2022.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$36.48	–
FY2024	Dec 31, 2024	-$8.05	–
FY2023	Dec 31, 2023	-$44.80	–
FY2022	Dec 31, 2022	-$5.95	–
FY2021	Dec 31, 2021	-$23.45	–
FY2020	Dec 31, 2020	-$12.60	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$16.65	–
Q1 FY2026	Mar 31, 2026	-$6.28	–
Q3 FY2025	Sep 30, 2025	-$22.17	–
Q2 FY2025	Jun 30, 2025	-$7.42	–
Q1 FY2025	Mar 31, 2025	-$2.26	–
Q3 FY2024	Sep 30, 2024	-$0.58	–
Q2 FY2024	Jun 30, 2024	-$7.67	–
Q1 FY2024	Mar 31, 2024	-$8.33	–
Q4 FY2023	Dec 31, 2023	-$7.71	–
Q3 FY2023	Sep 30, 2023	-$22.05	-493.8%
Q2 FY2023	Jun 30, 2023	-$6.65	–
Q1 FY2023	Mar 31, 2023	-$7.70	–
Q4 FY2022	Dec 31, 2022	-$4.54	–
Q3 FY2022	Sep 30, 2022	$5.60	–
Q2 FY2022	Jun 30, 2022	-$4.55	-786.1%
Q1 FY2022	Mar 31, 2022	-$2.45	–
Q3 FY2021	Sep 30, 2021	-$2.80	–
Q2 FY2021	Jun 30, 2021	-$0.35	–
Q1 FY2021	Mar 31, 2021	$0.66	–
Q3 FY2020	Sep 30, 2020	$0.00	–